Evidence map›Paper›PMID 42266550›Full record

ArticleCureus2026

Ovarian Endometrioid Carcinoma Presenting With Presumed Right Ventricular Intracardiac Metastasis and Superimposed Thrombus: A Rare Manifestation of Gynecologic Malignancy.

Muhammad Memon

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Muhammad MemonInternal Medicine, Christiana Care Health System, Newark, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac metastases are uncommon clinically, and intracavitary right ventricular involvement from gynecologic malignancies is exceedingly rare. We report a 69-year-old woman with multiple cardiovascular comorbidities and a recently diagnosed FIGO (International Federation of Gynecology and Obstetrics) grade 3 endometrioid carcinoma after having an exploratory laparotomy for a pelvic mass, resulting in total hysterectomy and bilateral salpingo-oophorectomy, with findings consistent with an ovarian mass and biopsy results showing endometrioid carcinoma. She was referred to the hospital after routine oncologic imaging raised concern for a right ventricular mass with associated thrombus. This patient had no symptoms on initial presentation and underwent further evaluation in the inpatient setting. Cardiac magnetic resonance imaging demonstrated a right ventricular structure extending into the right ventricular outflow tract with suspected enhancement at the attachment site to the interventricular septum, concerning for intracardiac metastatic disease with superimposed thrombus. Computed tomography of the chest demonstrated innumerable pulmonary nodules, concerning for hematogenous dissemination. Given prohibitive operative risk, surgical resection was deferred, and this was treated as presumed intracardiac metastasis with superficial thrombus. The patient was started on Warfarin for anticoagulation due to the cost-prohibitive effects of DOAC (direct oral anticoagulant) for the thrombotic component and discharged with oncology follow-up. This case highlights an exceptionally rare pattern of gynecologic malignancy involving the right ventricle, with diagnostic and therapeutic challenges related to distinguishing tumor from thrombus and balancing embolic risk against surgical morbidity.

Indexed as

gynecologic oncologyintracardiac thrombusintracardiac thrombus metastasismetastatic ovarian cancerovarian neoplasms

Identifiers

PMID42266550
PMCPMC13245268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.